Pharmaceutical Industry

Pharmacies take on bigger role in health care system, creating friction with doctors

McKinsey nears US$500-million settlement with DOJ over opioid probe, sources say

Johnson & Johnson lifts profit and sales forecasts, exceeds Wall Street expectations

Business Brief: Five takeaways before the long weekend

Market Factors: How sounding smarter can lose you money

Vaccine manufacturer won’t be making COVID shots at Montreal plant this winter

EU regulator reviews anti-baldness drugs over concerns of suicidal thoughts

Charity calls on B.C. political parties to expand pharmacare coverage for medication used to treat rare condition

Brookfield reaffirms its interest in Spanish drugmaker Grifols, requests more time for analysis: sources

Pharmacare advocates seek clarity on model proposed in bill before Senate

U.S. pharmacy middlemen won’t punish Novo Nordisk if it cuts weight-loss drug prices, Sanders says

Dose of uncertainty: Drug industry warns pharmacare bill could upend economic balance

New multiple sclerosis drug by Sanofi delays progressive form of disease by 31 per cent in trial

Three investment funds with holdings in drugmaker Grifols team up to ask for a board seat

Why AI is no miracle drug

Morning Update: The empty promise of AI-designed drugs

Revolution, interrupted: Why AI has failed to live up to the hype in drug development

RSV shot will be offered widely in Ontario and Quebec, but not in Western provinces

Eli Lilly appoints insider Lucas Montarce as finance chief amid rising investments to boost capacity